Mimedx (MDXG) Long-Term Deferred Tax (2015 - 2026)

Mimedx (MDXG) has 7 years of Long-Term Deferred Tax data on file, last reported at $24.1 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 12.85% year-over-year to $24.1 million; the trailing twelve-month figure through Mar 2026 stood at $24.1 million (down 12.85% YoY), and the FY2025 full-year result was $19.6 million, down 30.77% from the prior year.
• Long-Term Deferred Tax climbed to $24.1 million in Q1 2026, from $19.6 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $40.8 million in Q4 2023 to a low of $19.6 million in Q4 2025.
• A 4-year average of $29.2 million and a median of $28.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax slumped 30.77% in 2025 and retreated 12.85% in 2026, its largest moves.
• Tracing MDXG's Long-Term Deferred Tax over 4 years: stood at $40.8 million in 2023, then tumbled by 30.58% to $28.3 million in 2024, then tumbled by 30.77% to $19.6 million in 2025, then climbed by 23.12% to $24.1 million in 2026.
• Business Quant data shows MDXG's Long-Term Deferred Tax at $24.1 million in Q1 2026, $19.6 million in Q4 2025, and $21.6 million in Q3 2025.